Mar[2] - Raising Gear

SilverlakeAxis delivered impressive earning for last quarter. Gross profit up 32%, with both new projects and recurring income segment (ie maintenance, etc) registered double digits of growth. Having net cash ~ RM300mil, current price translates to dividend yield ~ 4%. Buying interest was strong since result released as highlighted on chart below. Recent price correction could present buying opportunity, considering the group is on the right track to deliver huge projects in pipeline. Earning prospects is convincing to shareholders as chart suggests.

SingMedical registered 48% growth in profit for FY2018. Being expanding its specialists clinics in SG, the group is aggressively penetrating into new geographies, such as Indonesia and Malaysia. Its' newly acquired clinic in Vietnam will operate on coming quarter. Recent announcement revealed that major shareholder, CHA group (South Korea's leading healthcare group) is going to raise stake onto the group through shares placement and loan scheme. CHA is enhancing corporation with the group for better exploration into new projects in overseas. Similarly, buying interest is surging on the counter upon latest announcement on earning and business plan from CHA as chart below suggests. Looking its peak of share price on 2018, current price presents huge room to grow.